Navigation Links
Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
Date:4/23/2008

SAN DIEGO, April 23 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced the release to television news stations nationwide of an independently produced video report featuring metastatic melanoma patients treated with the company's Allovectin-7(R) immunotherapeutic product candidate. The report is expected to be used broadly by stations in cities with clinical sites participating in Vical's Phase 3 Allovectin-7(R) trial, and in other cities by stations promoting melanoma awareness in May, which is National Melanoma/Skin Cancer Detection and Prevention Month. The two-minute video report was produced by MAX World News and is available by satellite feed to subscribing stations.

The video report features interviews with an oncologist and two of his patients who participated in earlier trials of Allovectin-7(R). Both patients had been treated previously with approved therapies and had refractory metastatic melanoma before receiving Allovectin-7(R). One patient had several metastatic tumors, including three in the liver, and had been advised that he should expect to live only three months. The other patient had a single metastatic tumor in a lymph node. Following treatment with Allovectin-7(R), both of these patients had complete remissions and have now been cancer-free for six and eight years, respectively.

About Allovectin-7(R)

Allovectin-7(R) is a plasmid/lipid complex containing the DNA sequences encoding HLA-B7 and .2 microglobulin, which together form a Class I Major Histocompatibility Complex, or MHC-I antigen. Injection of Allovectin-7(R) directly into tumors is designed to stimulate an immune response against both local and distant metastatic tumors. Vical conducted a large Phase 2 trial eval
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
3. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
6. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
7. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
8. New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a ... that Thomas M. Patton , President and ... Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at ... . The presentation is scheduled to begin ... will be available via a live webcast at http://wsw.com/webcast/marcum/casm/ ...
(Date:5/23/2013)... , May 23, 2013 Halozyme Therapeutics, ... the appointment of David A. Ramsay ... was most recently Vice President, Corporate Development at ... "With his established financial management experience ... by working in our commercial group for the ...
(Date:5/23/2013)... EarlySense, the market leader in ... for ,Best Novel Idea, at the 8 th ... Conference, hosted this year in the UK by the ... research team studying the impact of the EarlySense contact-free ... Los Angeles . The prize was awarded for ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4
... Capital, Inc. announced the initial closing of a private ... A total of 500,000 Units, each Unit consisting of ... purchase warrants, were sold, generating gross proceeds of approximately ... working capital and research and development related to Arrogene,s ...
... Conn., Jan. 19, 2012  The Specialty Photonics Division ... provider of optical fiber, cable, and assemblies for ... will present "Optical fibers with polyimide coatings for ... Dr. Stolov will present on Sunday, January 22nd ...
Cached Medicine Technology:WestPark Capital, Inc. Announces $500,000 Arrogene NanoTechnology, Inc. Offering 2OFS to Present Paper on Optical Fibers with Polyimide Coatings for Medical Applications 2
(Date:5/24/2013)... May 24, 2013 For the second ... Braeda Fresh Express Café to treat Tabitha Meals on ... to their door. More than 400 meal recipients recently ... the restaurants, along with the rest of a well-balanced, ... proud to partner with the Tabitha Meals on Wheels ...
(Date:5/24/2013)... The Lap Band Center now offers complementary ... Madan, head doctor at The Lap Band Center, if ... a change for the better, it is time to consider ... the risks that come with obesity and one way to ... healthily. , Obesity related diseases are no laughing matter, ...
(Date:5/24/2013)... Wednesday, 15th May 2013 | 10am BST | 5pm HKT ... http://bit.ly/10Rt0ZH , Ongoing regulatory changes are likely to ... and particularly in Europe, a number of these new regulatory ... dealmakers, understanding how the likes of Basel iii, Solvency II, ... of the market will give you a competitive edge and ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Scott Ryan ... brother, Troy Tischler, lose 200 lbs. of fat in ... Tischler teach his younger brother the importance of exercising. ... diet. By sticking to these 7 rules of healthy ... loss goals can be accomplished. , 1.    Find a distraction ...
(Date:5/23/2013)... 24, 2013 Magnatag’s new magnetic 365-Day ... and reduces vacation conflicts. A Manufacturing Manager from Augusta ... conflicts; now employees and managers can check the board ... Attendance is important to us and the board makes ... may seem harsh but it has made a difference.” ...
Breaking Medicine News(10 mins):Health News:Runza® Delivers Sandwiches, Draws Smiles from Tabitha Meals on Wheels Clients 2Health News:The Lap Band Center Announces That They Offer Complementary Consultation for First Time Patients 2Health News:The Lap Band Center Announces That They Offer Complementary Consultation for First Time Patients 3Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2
... proposed to initiate mass-production of a live bird flu vaccine ... the start of next year // in China. This ... a vaccine for humans. ,More than 1-billion ... the year-end. This would be a supplement to the already ...
... waves had left over 25,000 people dead and many more ... Indian Ocean countries. // One in five Thai ... that forever changed the physical, social and psychological landscape of ... interviews, an average of 20 percent of Thai tsunami survivors ...
... will make women more empowered. They have now developed ... completely.,The pill developed by New Jersey-based Wyeth and called ... and the inconvenience of periods. ,Critics have warned ... and breast cancer. They said continuous exposure to hormones ...
... give a false picture about coma survival and recovery rates ... felt // by coma patients and found that the ... not true as the study show that only 8% of ... with 50% upwards in real life. ,The recovery ...
... by researchers at Washington University School of Medicine in St. ... rapidly after treatment and are not as depressed as some ... of this study appear in the December issue of Supportive ... underwent radiation therapy at Siteman Cancer Center at Washington University ...
... picture of coma patients' survival and recovery, with potentially important ... storylines containing coma patients over 10 years, researchers found that ... coma than in real life. And they were also much ... of soap land patients died during coma, compared with over ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: